Traditional techniques for the synthesis of
nickel sulfide (NiS) nanoparticles (NPs) always present drawbacks of morphological irregularity, non-porous structure and poor long-term stability, which are extremely unfavorable for establishing effective therapeutic agents. Here, a category of hollow mesoporous NiS (hm-NiS) NPs with uniform spherical structure and good aqueous dispersity were innovatively developed based on a modified solvothermal reaction technique. Upon the successful synthesis of hm-NiS NPs,
dopamine was seeded and in situ polymerized into
polydopamine (PDA) on the NP surface, followed by functionalization with
thiol-
polyethylene glycol (SH-PEG) and encapsulation of the chemotherapeutic
drug,
doxorubicin (DOX), to form hm-NiS@PDA/PEG/DOX (NiPPD) NPs. The resultant NiPPD NPs exhibited a decent photothermal response and stability, attributed to the optical absorption of the hm-NiS nanocore and PDA layer in the near-infrared (NIR) region. Furthermore, stimulus-responsive drug release was achieved under both acidic pH conditions and NIR
laser irradiation, owing to the protonation of -NH2 groups in the DOX molecules and local thermal
shock, respectively. Lastly, a strong combinatorial photothermal-chemotherapeutic effect was demonstrated for
tumor suppression with minimal systemic toxicity in vivo. Collectively, this state-of-the-art paradigm may provide useful insights to deepen the application of hm-NiS NPs for disease management and
precision medicine.